57
Participants
Start Date
May 31, 2009
Primary Completion Date
February 29, 2012
Study Completion Date
August 31, 2013
Nilutamide
Nilutamide 150mg orally each day for 28 days per cycle. After first progression, Nilutamide 150mg orally each day in combination with Dasatinib 100mg orally each day for 28 days per cycle.
Dasatinib
Dasatinib 100mg orally daily x 28 days per cycle. After first progression, Dasatinib 100mg orally each day in combination with Nilutamide 150mg orally each day for 28 days per cycle.
Duke University Medical Center, Durham
Oregon Health and Science University, Portland
University of Washington/Seattle Cancer Care Alliance, Seattle
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Duke University
OTHER